| 1 | Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD h-f801d7a726 | TARDBP | proposed | — | 2026-05-14 | Open → |
| 2 | Rational design of small molecules targeting TDP-43 liquid-to-solid phase trans… h-fc57d8e73d | TARDBP | proposed | — | 2026-05-14 | Open → |
| 3 | TDP-43 RNA-proteostasis failure across ALS, FTD, and AD/LATE h-cross-synth-tdp43-rna-proteostasis | TARDBP | validated | 0.828 | 2026-05-14 | Open → |
| 4 | STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker of TDP-43… ec8b839c-6440-45dc-aff6-5edea1fd2d6d | TARDBP | open | 0.760 | 2026-05-13 | Open → |
| 5 | Cross-Seeding Prevention Strategy h-eea667a9 | TARDBP | debated | 0.689 | 2026-05-13 | Open → |
| 6 | Glial Neuroinflammatory Amplification by TDP-43 Pathology h-f909089218 | TARDBP | proposed | 0.680 | 2026-05-14 | Open → |
| 7 | TDP-43 Liquid-Liquid Phase Separation Dominance in Stress Granules Predisposes… h-analogy-9e00d99e | TARDBP | active | 0.650 | 2026-05-16 | Open → |
| 8 | Glycine-Rich Domain Competitive Inhibition h-7e846ceb | TARDBP | debated | 0.640 | 2026-05-16 | Open → |
| 9 | Synaptic RNA Metabolism Dysregulation h-a00d94b8c8 | TARDBP | proposed | 0.620 | 2026-05-14 | Open → |
| 10 | Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autoph… h-aa7eae0c3a | TARDBP | proposed | 0.600 | 2026-05-14 | Open → |
| 11 | TDP-43 LLPS and proteostasis dysregulation in ALS/FTD h-30afe4733d | TARDBP | proposed | 0.600 | 2026-05-14 | Open → |
| 12 | TDP-43 Co-pathology Subtype Identified Through Motor Neuron Transcriptomics h-0ad03dd59c | TARDBP | proposed | 0.564 | 2026-05-13 | Open → |
| 13 | Cryptic Exon Silencing Restoration h-4fabd9ce | TARDBP | debated | 0.531 | 2026-05-13 | Open → |
| 14 | G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-Spreads Across Neur… h-588406cca9 | TARDBP | proposed | 0.490 | 2026-05-14 | Open → |
| 15 | RNA-Binding Competition Therapy for TDP-43 Cross-Seeding h-7693c291 | TARDBP | archived | 0.465 | 2026-05-13 | Open → |
| 16 | RNA Granule Phase Separation as Transient Cross-Seeding Hub hyp-sda-2026-04-01-gap-9137255b-3 | TARDBP | active | 0.455 | 2026-05-13 | Open → |
| 17 | Membraneless Organelle Stabilizers Targeting Low-Complexity Domains h-debate-ca7cd06fbe99 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 18 | ATP-Mimetic Phase Separation Modulators h-debate-6a7ac6e2b89d | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 19 | Phase Transition Kinetics Modulators h-debate-bccf51838ea3 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 20 | Nuclear Import Receptor Enhancers as Phase Separation Modulators h-debate-2bd1fc31f6e5 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 21 | RNA Splicing Corrector Compounds h-debate-0425e09671f7 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 22 | Prion-Like Domain Stabilizers via Aromatic Interaction Modulators h-debate-d71b812a7569 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 23 | C-Terminal Frameshift Protection via RNA-Guided Editing h-debate-07f363d7e989 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 24 | Bi-functional Nuclear Trafficking-Phase Separation Modulators h-debate-8065828c3643 | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |
| 25 | Nuclear Import Receptor Enhancers h-debate-ac3b63c9a8ec | TARDBP | proposed | 0.000 | 2026-05-14 | Open → |